Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (7099Y)
May 14 2021 - 6:10AM
UK Regulatory
TIDMAMS
RNS Number : 7099Y
Advanced Medical Solutions Grp PLC
14 May 2021
14 May 2021
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company , announces
that the Trust which manages the Deferred Share Bonus Plan ("DSB")
on behalf of the employees of AMS has purchased ordinary shares of
5 pence each ("Ordinary Shares") on 11 May 2021, at a price of
272.09p on behalf of Chris Meredith and Eddie Johnson, who are both
Directors and PDMRs, as part of the DSB and, under the terms of the
DSB, these shares will be held in trust on their behalf.
The announcement made on 14 April 2021 explained that Chris
Meredith and Eddie Johnson were selling shares, the p roceeds of
which would be used to purchase shares in the DSB. The purchases
outlined above complete that process.
Following these transactions the beneficial ownership of Chris
Meredith and Eddie Johnson are as follows:
Director/PDMR Date purchased Shares purchased Resultant % of issued
(through DSB) holding share capital
Chris Meredith
Chief Executive
Officer 11 May 2021 13,855 1,523,900 0.7%
================ ================= ========== ===============
Eddie Johnson
Chief Financial
Officer 11 May 2021 9,606 75,634 0.03%
================ ================= ========== ===============
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Purchase of 13,855 Ordinary Shares as part of the
Deferred Share Bonus Plan on 11 May 2021 at a price
of 272.09p
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 11/05/2021
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Eddie Johnson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Purchase of 9,606 Ordinary Shares as part of the
Deferred Share Bonus Plan on 11 May 2021 at a price
of 272.09p
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 11/05/2021
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Matthew AMS@consilium-comms.com
Cole
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Gary Clarence / Patrick
Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and woundcare markets, focused on quality outcomes for
patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. In 2019, the Group made two acquisitions: Sealantis,
an Israeli medical device company with a patent-protected sealant
technology platform; and Biomatlante, an established developer and
manufacturer of innovative surgical biomaterial technologies based
in France. In 2020, the Group acquired Raleigh Adhesive Coatings, a
leading coater and converter of materials predominately for
woundcare and bio-diagnostics products based in the UK.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Germany, the
Czech Republic and Russia. The Group has R&D innovation hubs in
the UK, Germany, France and Israel. Established in 1991, the Group
has approximately 700 employees. For more information, please see
www.admedsol.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBBGDUIGBDGBS
(END) Dow Jones Newswires
May 14, 2021 07:10 ET (11:10 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024